The CA 125 test may be recommended in several scenarios:
To screen women who are at a high risk of ovarian cancer, especially those with a family history of the disease. To monitor the effectiveness of treatment in women who have been diagnosed with ovarian cancer. To detect the recurrence of ovarian cancer after treatment. In some cases, the test may be used to evaluate other gynecological conditions such as endometriosis or pelvic inflammatory disease (PID).
